[1] Di Nisio M, van Es N, Büller H R. Deep vein thrombosis and pulmonary embolism[J]. Lancet, 2016,17,388(10063):3060-3073. [2] Kiluk I E, Krajewska A, Kosacka U, et al. Different manifestations of pulmonary embolism in younger compared to older patients:clinical presentation,prediction rules and long-term outcomes[J]. Adv Med Sci, 2017,62(2):254-258. [3] 孙明利,冯亚平,黄俊,等. 住院患者深静脉血栓形成的临床特征[J].中华内科杂志,2017,56(12):914-918. [4] Hong J, Lee J H,Yhim H Y, et al. Incidence of venous thromboembolism in Korea from 2009 to 2013[J].PLoS One,2018,25,13(1):e0191897. [5] Højen A A, Sørensen E E, Dreyer P S, et al. Long-term mental wellbeing of adolescents and young adults diagnosed with venous thromboembolism:results from a multistage mixed methods study[J].J Thromb Haemost,2017,15(12):2333-2343. [6] 中华医学会外科学分会.2008深静脉血栓形成的诊断和治疗指南[J].中华普通外科杂志,2008,23(3):235-238. [7] 中国医学会心血管病学分会.2010急性肺血栓栓塞症诊断治疗中国专家共识[J].中华内科杂志,2010,49(1):74-81. [8] Mansour S, Alotaibi G, Wu C,et al.Sex disparities in hospitalization and mortality rates for venous thromboembolism[J]. J Thromb Thrombolysis,2017,44(2):197-202. [9] Kowalski J, Jędrzejczyk J T, Barylski M, et al.Value of D-dimer and HDL cholesterol concentrations in predicting the occurrence of acute pulmonary embolism[J].Pol Merkur Lekarski,2016,40(239):283-287. [10] Flores J, Lancha C, Pérez Rodríguez E.Efficacy of D-dimer and total fibrin degradation products evaluation in suspected pulmonary embolism[J].Respiration,1995,62(5):258-262. [11] Karalezli A, Parlak E S, Kanbay A, et al. Homocysteine and serum-lipid levels in pulmonary embolism[J]. Clin Appl Thromb Hemost,17(6):E186-E189. [12] Misra P, Ghosh A K, Jassar A. Autopsy findings in an atypical case of occult massive fatal pulmonary embolism in a backdrop of hyperhomocysteinemia[J]. Indian J Pathol Microbiol, 2018, 61(1):116-119. [13] Quist-Paulsen P, Naess I A, Cannegieter S C, et al. Arterial cardiovascular risk factors and venous thrombosis:results from apopulation-based, prospective study (the HUNT 2)[J]. Haematologica,2010,95(1):119-125. [14] Hald E M, Brakkan S K, Mathiesen E B,et al. High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism:the Tromso study[J]. Haematologica,2011,96(8):1189-1194. [15] Frasson S, Gussoni G, Di Micco P. Infection as cause of immobility and occurrence of venous thromboembolism:analysis of 1635 medical cases from the RIETE registry[J]. J Thromb Thrombolysis,2016,41(3):404-412. [16] Kovacs M J, Kahn S R, Wells P S, et al.Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism[J]. J Thromb Haemost,2010,8(9):1926-1932. [17] Ouriel K,Green R M,Greenberg R K,et al. The anatomy of deep venous thrombosis of the lower extremity[J]. J Vasc Surg,2000,31(5):895-900. [18] Hotoleanu C. Genetic risk factors in venous thromboembolism[J].Adv Exp Med Biol,2017,906:253-272. [19] 李金玉, 程爱斌,王红阳,等.Padua模型预测慢性阻塞性肺疾病患者深静脉血栓形成的有效性[J].中国煤炭工业医学杂志,2017,20(11):1344-1349. |